CI vs PRME · P/E 2.4, rev $274.90B vs rev $3.0M
Cigna Corp (CI) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PRME currently screens at market cap $570.8M.
Not investment advice. Open the CI and PRME stock pages for the full models.
Not investment advice.